Sugi Predict

Sugi Predict / Compounds / SCHEMBL998182

SCHEMBL998182

SCHEMBL998182

COc1ccc2ccccc2c1-c1c(OC)ccc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 1.00
▸ NQO1 P15559 1/20 0.61
▸ MEN1 O00255 4/20 0.60
▸ KMT2A Q03164 4/20 0.60
▸ NISCH Q9Y2I1 1/20 0.60
▸ ALDH1A1 P00352 3/20 0.59
▸ RAB9A P51151 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ KDM4E B2RXH2 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ TDP1 Q9NUW8 2/20 0.48
▸ CYP2A6 P11509 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ NQO2 P16083 1/20 0.47
▸ IDO1 P14902 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ DUSP3 P51452 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29428410 1.00 MAPT (1.00) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL22534454 0.94 MAPT (0.88) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL31336201 0.94 MAPT (0.88) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL26737425 0.90 MAPT (0.81) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL18789299 0.90 MAPT (0.81) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL12507163 0.90 MAPT (0.81) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL11588332 0.90 MAPT (0.81) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL369163 0.90 MAPT (0.81) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL12994034 0.89 MAPT (0.79) MAPTNQO1MEN1KMT2ANISCH
SCHEMBL6563131 0.89 MAPT (0.79) MAPTNQO1MEN1KMT2ANISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11186660-B2 Internal electron donor compound for preparing α-olefin polymerization catalyst component YINGKOU XIANGYANG CATALYST CO., LTD. 2021-11-30 — — US claimed
US-20190218317-A1 INTERNAL ELECTRON DONOR COMPOUND FOR PREPARING ALPHA-OLEFIN POLYMERIZATION CATALYST COMPONENT YINGKOU XIANGYANG CATALYST CO LTD (CN) 2019-07-18 — — US claimed
US-10287371-B2 Internal electron donor compound for preparing α-olefin polymerization catalyst component YINGKOU XIANGYANG CATALYST CO., LTD. (CN) 2019-05-14 — — US claimed
US-20160229935-A1 Internal Electron Donor Compound for Preparing Alpha-olefin Polymerization Catalyst Component DALIAN UNIVERSITY OF TECHNOLOGY (CN) 2016-08-11 — — US claimed
EP-2343285-B1 Peptoid compounds useful as antibiotics UNIV WOLLONGONG (AU) 2015-02-25 — — EP claimed
US-20120108499-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2012-05-03 — — US claimed
EP-2343285-A2 Peptoid compounds UNIVERSITY OF WOLLONGONG (AU) 2011-07-13 — — EP claimed
US-20100167995-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2010-07-01 — — US claimed
JP-4446736-B2 — — 2010-04-07 — — JP claimed
EP-1412336-A4 PEPTOID COMPOUNDS UNIV WOLLONGONG (AU) 2007-08-29 — — EP claimed
US-20070111927-A1 Peptoid compounds UNIVERSITY OF WOLLONGONG (AU) 2007-05-17 — — US claimed
US-7160854-B2 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections UNIVERSITY OF WOLLONGONG (AU) 2007-01-09 — — US claimed
US-20050043509-A1 Peptoid compounds UNIVERSITY OF WOLLONGONG 2005-02-24 — — US claimed
JP-2005504734-A — — 2005-02-17 — — JP claimed
EP-1412336-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2004-04-28 — — EP claimed
WO-2003002545-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2003-01-09 — — WO claimed
US-20250125394-A1 HIGH-TEMPERATURE POLYMER ELECTROLYTE MEMBRANE FUEL CELL AND METHOD OF MANUFACTURING THE SAME KIA CORPORATION (KR) 2025-04-17 — — US disclosed
US-20250011590-A1 OPTICAL FILM AND POLARIZING PLATE TOSOH CORPORATION (JP) 2025-01-09 — — US disclosed
EP-0358129-A1 New Crown ether compound and separating agent Director General, Agency of Industrial Science and Technology (JP) 1990-03-14 — — EP disclosed
US-4284581-A LITHIUM 1,1'-BINAPHTHYL-2,2'-DIOXYALUMINUM HYDRIDE, REDUCING AGENTS ONO PHARMACEUTICAL CO., LTD. (JP) 1981-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108499-A1 PEPTOID COMPOUNDS VIP, FPR1, VIPR1 MAPT 3267/4885NQO1 3011/4885MEN1 3065/4885
US-20100167995-A1 PEPTOID COMPOUNDS VIP, FPR1, VIPR1 MAPT 3267/4885NQO1 3011/4885MEN1 3065/4885
US-20070111927-A1 Peptoid compounds VIP, FPR1, VIPR1 MAPT 3267/4885NQO1 3011/4885MEN1 3065/4885
US-20050043509-A1 Peptoid compounds VIP, FPR1, VIPR1 MAPT 3267/4885NQO1 3011/4885MEN1 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.